Biological variation of insulin resistance, testosterone and cardiovascular risk factors in women with polycystic ovary syndrome: modification with rimonabant compared to metformi
Completed
- Conditions
- PolyCystic Ovary Syndrome (PCOS)Nutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN75758249
- Lead Sponsor
- Hull and East Yorkshire Hospitals NHS Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
1. Polycystic ovarian syndrome
2. Body Mass Index (BMI) greater than 30 kg/m^2
Exclusion Criteria
1. Patient should not be on any drugs
2. Unwilling for General Practitioner (GP) to be informed
3. Diabetic patients
4. Uncompensated hypothyroidism
5. Patients not on barrier contraception
6. History of psychiatric disorder or severe depression
7. Chronic renal failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method